Trials / Completed
CompletedNCT03127423
Comparison Between One-stage Hybrid Ablation and Thoracoscopic Surgical Ablation for Intractable Atrial Fibrillation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- China National Center for Cardiovascular Diseases · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Previous evidence indicated that the outcomes of both video-assisted thoracoscopic surgical ablation and percutaneous radiofrequency ablation therapy for persistent atrial fibrillation (AF) were unsatisfied. Recently, hybrid ablation therapy for AF had encouraging outcomes. However, there were no randomized, controlled clinical studies to prove the effectiveness of this new strategy. This study is aimed to compare the outcomes of hybrid ablation with video-assisted thoracoscopic surgical ablation for persistent AF with enlarged left atrium.
Detailed description
This study is aimed to compare the outcomes of hybrid ablation with video-assisted thoracoscopic surgical ablation for persistent AF with enlarged left atrium.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Hybrid ablation | This intervention includes totally thoracoscopic surgical ablation and percutaneous catheter ablation simultaneously. |
| PROCEDURE | Thoracoscopic surgical ablation | This intervention only includes totally thoracoscopic surgical ablation without percutaneous catheter ablation. |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
- First posted
- 2017-04-25
- Last updated
- 2023-04-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03127423. Inclusion in this directory is not an endorsement.